Skip to content

Randomized controlled clinical trial comparing Zhi Hui Su with Cognitive Behavioral Therapy for sleep-related issues in children with neurodevelopmental disorders

Randomized controlled clinical trial comparing Zhi Hui Su with Cognitive Behavioral Therapy for sleep-related issues in children with neurodevelopmental disorders

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113210
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), Language Disorder, Intellectual Developmental Disorder (IDD), and Developmental Learning Disorder are all neurodevelopmental disorders.

Interventions

Sponsors

Guangzhou Women and Children's Medical Center,Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Age 1-10 years, meeting the diagnostic criteria for neurodevelopmental disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); 2. The child has sleep-related issues (CSHQ >=42 points [31], sleep latency: >30 minutes or nocturnal awakenings >=3 times/night); 3. Guardians or legal representatives must sign a written informed consent form, committing to completing the 3-month follow-up and participating throughout the intervention process; 4. Written informed consent is required for children aged >=8 years.

Exclusion criteria

Exclusion criteria: 1.The child has a serious organic disease (such as congenital heart disease, liver or kidney dysfunction); 2. Has used psychiatric drugs that may affect sleep or emotional function within the past 3 months (such as atomoxetine, melatonin, escitalopram, etc.), or is participating in other similar clinical trials; 3. Has known allergies to the core components of Zhihui Su (ferulic acid, PS, Angelica extract), or has a history of severe food allergies; 4.The child cannot cooperate with intervention and assessment due to behavioral problems (such as aggressive behavior, severe self-harm).

Design outcomes

Primary

MeasureTime frame
Brief Infant Sleep Questionnaire;Children’s Sleep Habits Questionnaire;

Secondary

MeasureTime frame
Infant Behavior Questionnaire-Revised;Pediatric Quality of Life Inventory;Emotion Regulation Checklist, ERC;Adverse Event Record ;

Countries

China

Contacts

Public ContactXu Kaishou

Guangzhou Women and Children's Medical Center,Guangzhou Medical University

xksyi@126.com+86 20 8133 0645

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026